Actinium Pharmaceuticals (ATNM) Competitors $1.49 -0.10 (-6.29%) Closing price 04:00 PM EasternExtended Trading$1.49 0.00 (0.00%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATNM vs. DRUG, CRGX, IPHA, NBTX, TIL, SOPH, BTMD, KOD, NVCT, and INBXShould you be buying Actinium Pharmaceuticals stock or one of its competitors? The main competitors of Actinium Pharmaceuticals include Bright Minds Biosciences (DRUG), CARGO Therapeutics (CRGX), Innate Pharma (IPHA), Nanobiotix (NBTX), Instil Bio (TIL), SOPHiA GENETICS (SOPH), biote (BTMD), Kodiak Sciences (KOD), Nuvectis Pharma (NVCT), and Inhibrx (INBX). These companies are all part of the "pharmaceutical products" industry. Actinium Pharmaceuticals vs. Its Competitors Bright Minds Biosciences CARGO Therapeutics Innate Pharma Nanobiotix Instil Bio SOPHiA GENETICS biote Kodiak Sciences Nuvectis Pharma Inhibrx Bright Minds Biosciences (NASDAQ:DRUG) and Actinium Pharmaceuticals (NYSE:ATNM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, community ranking, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Do institutionals & insiders believe in DRUG or ATNM? 40.5% of Bright Minds Biosciences shares are owned by institutional investors. Comparatively, 27.5% of Actinium Pharmaceuticals shares are owned by institutional investors. 42.7% of Bright Minds Biosciences shares are owned by company insiders. Comparatively, 6.0% of Actinium Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor DRUG or ATNM? Bright Minds Biosciences and Actinium Pharmaceuticals both received 11 outperform votes by MarketBeat users. However, 91.67% of users gave Bright Minds Biosciences an outperform vote while only 47.83% of users gave Actinium Pharmaceuticals an outperform vote. CompanyUnderperformOutperformBright Minds BiosciencesOutperform Votes1191.67% Underperform Votes18.33%Actinium PharmaceuticalsOutperform Votes1147.83% Underperform Votes1252.17% Do analysts recommend DRUG or ATNM? Bright Minds Biosciences currently has a consensus price target of $83.25, suggesting a potential upside of 201.85%. Actinium Pharmaceuticals has a consensus price target of $4.00, suggesting a potential upside of 168.46%. Given Bright Minds Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Bright Minds Biosciences is more favorable than Actinium Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Actinium Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more risk & volatility, DRUG or ATNM? Bright Minds Biosciences has a beta of -5.75, indicating that its share price is 675% less volatile than the S&P 500. Comparatively, Actinium Pharmaceuticals has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Which has stronger earnings & valuation, DRUG or ATNM? Bright Minds Biosciences has higher earnings, but lower revenue than Actinium Pharmaceuticals. Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Actinium Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright Minds BiosciencesN/AN/A-$2.06M-$0.36-76.61Actinium Pharmaceuticals$81K573.85-$48.82M-$1.39-1.07 Is DRUG or ATNM more profitable? Bright Minds Biosciences' return on equity of -5.85% beat Actinium Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Bright Minds BiosciencesN/A -5.85% -5.68% Actinium Pharmaceuticals N/A -100.85%-47.89% Does the media prefer DRUG or ATNM? In the previous week, Bright Minds Biosciences had 5 more articles in the media than Actinium Pharmaceuticals. MarketBeat recorded 6 mentions for Bright Minds Biosciences and 1 mentions for Actinium Pharmaceuticals. Bright Minds Biosciences' average media sentiment score of 1.11 beat Actinium Pharmaceuticals' score of 0.00 indicating that Bright Minds Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bright Minds Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Actinium Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBright Minds Biosciences beats Actinium Pharmaceuticals on 13 of the 16 factors compared between the two stocks. Get Actinium Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATNM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATNM vs. The Competition Export to ExcelMetricActinium PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$46.48M$6.85B$5.56B$19.63BDividend YieldN/A2.53%5.28%3.82%P/E Ratio-1.078.4326.6435.03Price / Sales573.85262.52407.9942.85Price / CashN/A65.8538.2517.51Price / Book1.146.536.974.78Net Income-$48.82M$143.25M$3.23B$1.02B7 Day Performance-18.58%0.21%-0.98%-0.35%1 Month Performance-1.97%10.92%7.70%1.04%1 Year PerformanceN/A2.44%31.32%9.19% Actinium Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNMActinium Pharmaceuticals1.1969 of 5 stars$1.49-6.3%$4.00+168.5%N/A$46.48M$81K-1.0730DRUGBright Minds Biosciences3.3117 of 5 stars$28.32+9.1%$83.25+194.0%+2,552.3%$199.49MN/A-166.58N/APositive NewsAnalyst RevisionGap DownCRGXCARGO Therapeutics2.3804 of 5 stars$4.28+0.7%$15.00+250.5%-73.8%$197.35MN/A-1.00116Positive NewsIPHAInnate Pharma3.1317 of 5 stars$2.14-2.2%$11.00+413.8%-19.5%$197.35M$12.62M0.00220Positive NewsGap DownNBTXNanobiotix2.6844 of 5 stars$4.13+0.8%$8.00+93.5%+8.3%$194.85M-$11.61M0.00100Positive NewsShort Interest ↓Gap DownTILInstil Bio2.9952 of 5 stars$29.65+10.0%$112.33+278.9%+248.6%$194.47MN/A-2.56410Short Interest ↑Gap UpHigh Trading VolumeSOPHSOPHiA GENETICS1.7982 of 5 stars$2.91-3.0%$6.80+133.7%-39.6%$194.06M$67.17M-2.67520News CoveragePositive NewsBTMDbiote3.8492 of 5 stars$3.54+2.3%$8.00+126.0%-40.4%$193.67M$199.38M13.62194Positive NewsKODKodiak Sciences4.203 of 5 stars$3.60+5.9%$9.00+150.0%+31.9%$189.95MN/A-0.9990Short Interest ↓Gap DownNVCTNuvectis Pharma2.947 of 5 stars$8.98-4.6%$17.00+89.3%+32.8%$187.63MN/A-7.748News CoveragePositive NewsINBXInhibrx2.8817 of 5 stars$12.96-3.8%N/A-13.3%$187.61M$200K0.11166Positive NewsUpcoming EarningsGap Down Related Companies and Tools Related Companies Bright Minds Biosciences Alternatives CARGO Therapeutics Alternatives Innate Pharma Alternatives Nanobiotix Alternatives Instil Bio Alternatives SOPHiA GENETICS Alternatives biote Alternatives Kodiak Sciences Alternatives Nuvectis Pharma Alternatives Inhibrx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ATNM) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATNM Stock Free ATNM Stock Alerts